Pancreatic Lesion

MRI is a powerful tool for detection, characterization, and surveillance of both cystic pancreatic lesions, such as serous and mucinous tumors, and intraductal papillary mucinous tumors, as well as neuroendocrine tumors. Because the MR signal is so sensitive to fluid, fluids in the cystic lesions as well as in the ducts are well depicted. Historically, neuroendocrine tumors have been more challenging to evaluate because of their small size and the short time window between when an intravenously injected contrast material reaches the tumor and the rest of the normal pancreas. However, Stanford researchers have developed a suite of tools that provide unprecedented high resolution images with fast snapshots that have helped detect these small lesions.

Download Request Form
Pancreatic serous cystadenoma.
Pancreatic serous cystadenoma.
Pancreatic neuroendocrine tumor Pancreatic neuroendocrine tumor detected on diffusion-weighted MRI
Pancreatic neuroendocrine tumor Pancreatic neuroendocrine tumor detected on diffusion-weighted MRI
Dynamic contrast enhanced MRI detected pancreatic neuroendocrine tumor. Pancreatic neuroendocrine tumor captured by fast MRI after injection of intravenous contrast
Dynamic contrast enhanced MRI detected pancreatic neuroendocrine tumor. Pancreatic neuroendocrine tumor captured by fast MRI after injection of intravenous contrast
References
  1. Kalb B, Sarmiento JM, Kooby DA, Adsay NV, Martin DR. MR imaging of cystic lesions of the pancreas. Radiographics 2009; 29:1749-1765. PubMed link
  2. Ku YM, Shin SS, Lee CH, Semelka RC. Magnetic resonance imaging of cystic and endocrine pancreatic neoplasms. Top Magn Reson Imaging 2009; 20:11-18. PubMed link
  3. Manfredi R, Graziani R, Motton M, et al. Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis. Radiology 2009; 253:106-115. PubMed link
  4. Park HS, Lee JM, Choi HK, Hong SH, Han JK, Choi BI. Preoperative evaluation of pancreatic cancer: comparison of gadolinium-enhanced dynamic MRI with MR cholangiopancreatography versus MDCT. J Magn Reson Imaging 2009; 30:586-595. PubMed link
  5. Rha SE, Jung SE, Lee KH, Ku YM, Byun JY, Lee JM. CT and MR imaging findings of endocrine tumor of the pancreas according to WHO classification. Eur J Radiol 2007; 62:371-377. PubMed link
  6. Sahani DV, Kadavigere R, Saokar A, Fernandez-del Castillo C, Brugge WR, Hahn PF. Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics 2005; 25:1471-1484. PubMed link
  7. Schima W, Ba-Ssalamah A, Goetzinger P, Scharitzer M, Koelblinger C. State-of-the-art magnetic resonance imaging of pancreatic cancer. Top Magn Reson Imaging 2007; 18:421-429. PubMed link
  8. Song SJ, Lee JM, Kim YJ, et al. Differentiation of intraductal papillary mucinous neoplasms from other pancreatic cystic masses: comparison of multirow-detector CT and MR imaging using ROC analysis. J Magn Reson Imaging 2007; 26:86-93. PubMed link
  9. Wang Y, Miller FH, Chen ZE, et al. Diffusion-weighted MR imaging of solid and cystic lesions of the pancreas. Radiographics 2011; 31:E47-64. PubMed link
css.php